Change Agents Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Public

  • Employees
  • 2

Employees

  • Stock Symbol
  • CHGA

Stock Symbol

  • Investments
  • 8

  • Share Price
  • $0.89
  • (As of Monday Closing)

Change Agents General Information

Description

Change Agents Corp is an artificial intelligence software company focused on developing agentic AI applications designed to help small businesses, brands, and content creators increase revenue, improve digital discoverability, and automate content creation. The company's current portfolio includes Beacon, an AI Search Optimization platform, and Catch-Up, an autonomous AI-powered content creation platform. Through its scalable Software-as-a-Service (SaaS) business model, it is focused on delivering AI solutions that create measurable customer value while generating recurring subscription revenue and long-term shareholder returns.

Contact Information

Formerly Known As
Avalon GloboCare
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 4400 Route 9 South
  • Suite 3100
  • Freehold, NJ 07728
  • United States
+1 (732)
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 4400 Route 9 South
  • Suite 3100
  • Freehold, NJ 07728
  • United States
+1 (732)

Change Agents Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Change Agents Stock Performance

As of 16-Nov-2026, Change Agents’s stock price is $0.89. Its current market cap is $1.12M with 1.25M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.89 $1.07 $0.69 - $37.65 $1.12M 1.25M 690K -$2.80

Change Agents Financials Summary

As of 30-Jun-2026, Change Agents has a trailing 12-month revenue of $350K.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 30,969 24,643 31,258 33,074
Revenue 350 0 0 1,256
EBITDA (6,494) (15,903) (5,257) (15,026)
Net Income (8,979) (18,261) (7,903) (16,707)
Total Assets 14,721 23,401 20,985 20,583
Total Debt 1,335 940 2,124 8,506
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Change Agents Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Change Agents‘s full profile, request access.

Request a free trial

Change Agents Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Change Agents Corp is an artificial intelligence software company focused on developing agentic AI applications designed
Biotechnology
Freehold, NJ
2 As of 2025

Oxford, United Kingdom
 

Secaucus, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Change Agents Competitors (4)

One of Change Agents’s 4 competitors is Evox Therapeutics, a Venture Capital-Backed company based in Oxford, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Evox Therapeutics Venture Capital-Backed Oxford, United Kingdom
Quest Diagnostics Corporation Secaucus, NJ
Bio-Rad Laboratories Corporation Hercules, CA
Kimera Labs Corporation Miramar, FL
To view Change Agents’s complete competitors history, request access »

Change Agents Patents

Change Agents Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220031836-A1 Emulsomes comprising s-layer fusion proteins and methods of use thereof Inactive 03-Aug-2020
WO-2022031376-A1 Emulsomes comprising s-layer fusion proteins and methods of use thereof Inactive 03-Aug-2020
US-20210403509-A1 S-layer vaccine fusion proteins and methods of use Inactive 24-Jun-2020
WO-2021262625-A1 S-layer vaccine fusion proteins and methods of use Inactive 24-Jun-2020
US-11401320-B2 Qty fc fusion receptor proteins Active 31-Mar-2020 C07K14/7158
To view Change Agents’s complete patent history, request access »

Change Agents Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Change Agents Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Change Agents‘s full profile, request access.

Request a free trial

Change Agents Investments & Acquisitions (8)

Change Agents’s most recent deal was a Merger/Acquisition with RPM Interactive for . The deal was made on 15-Dec-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
RPM Interactive 15-Dec-2025 Merger/Acquisition Multimedia and Design Software
Laboratory Services MSO 09-Feb-2023 Secondary Transaction - Private Laboratory Services (Healthcare)
Hebei Senlangbio Biotechnology 14-Jun-2021 Merger/Acquisition Drug Discovery
Cellular Immunotherapy (Arbele/Avalon GloboCare) 23-Oct-2018 Joint Venture Drug Discovery
Epicon Biotech 01-Sep-2018 Joint Venture Biotechnology
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

Change Agents ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

37.86 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Biotechnology

Subindustry

of 431

Rank

Percentile

To view Change Agents’s complete esg history, request access »

Change Agents Exits (1)

Change Agents’s most recent exit was on 15-Dec-2025 from RPM Interactive. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
RPM Interactive 15-Dec-2025 Completed
To view Change Agents’s complete exits history, request access »

Change Agents Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
RPM Interactive New Brunswick, NJ 2022

Change Agents FAQs

  • When was Change Agents founded?

    Change Agents was founded in 2014.

  • Where is Change Agents headquartered?

    Change Agents is headquartered in Freehold, NJ.

  • What is the size of Change Agents?

    Change Agents has 2 total employees.

  • What industry is Change Agents in?

    Change Agents’s primary industry is Biotechnology.

  • Is Change Agents a private or public company?

    Change Agents is a Public company.

  • What is Change Agents’s stock symbol?

    The ticker symbol for Change Agents is CHGA.

  • What is the current stock price of Change Agents?

    As of 16-Nov-2026 the stock price of Change Agents is $0.89.

  • What is the current market cap of Change Agents?

    The current market capitalization of Change Agents is $1.12M.

  • What is Change Agents’s current revenue?

    The trailing twelve month revenue for Change Agents is $350K.

  • Who are Change Agents’s competitors?

    Evox Therapeutics, Quest Diagnostics, Bio-Rad Laboratories, and Kimera Labs are competitors of Change Agents.

  • What is Change Agents’s annual earnings per share (EPS)?

    Change Agents’s EPS for 12 months was -$2.80.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process